Highland Private Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-569
Closed -$259K 48
2022
Q3
$259K Buy
569
+9
+2% +$4.31K 0.04% 150
2022
Q2
$270K Buy
560
+16
+3% +$7.92K 0.04% 142
2022
Q1
$268K Buy
544
+45
+9% +$20.6K 0.04% 151
2021
Q4
$232K Buy
+499
New +$210K 0.03% 167

Other funds holding ELV

Highland Private Wealth Management's ELV Position: Q4 2022 in Review

Highland Private Wealth Management sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 569 shares — an estimated $259K sold.

Highland Private Wealth Management first reported a position in ELV in Q4 2021 and held it in 4 quarters. The position peaked at $270K in Q2 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Highland Private Wealth Management reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Highland Private Wealth Management sold 569 Elevance Health shares in Q4 2022, an estimated $259K.
  • Highland Private Wealth Management first reported a position in Elevance Health in Q4 2021 and held it in 4 quarters.
  • Highland Private Wealth Management's Elevance Health position peaked at $270K in Q2 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Highland Private Wealth Management's 13F filing for Q4 2022.